Clinical Trials Directory

Trials / Completed

CompletedNCT01440504

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Centre Francois Baclesse · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to quantify the ex vivo induction of apoptosis by ABT-737 + association platinum in samples exposed and demonstrate the value of this combination compared to the agents used alone.

Conditions

Interventions

TypeNameDescription
OTHERculture ex vivo with exposure to different therapeutic agents alone or in combination.When tumor resection, tumor specimens of ovarian cancer will be made towards a culture ex vivo with exposure to different therapeutic agents alone or in combination.

Timeline

Start date
2010-04-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2011-09-26
Last updated
2013-02-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01440504. Inclusion in this directory is not an endorsement.

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovar (NCT01440504) · Clinical Trials Directory